When used as hosts in passive transfer experiments, a stock of NOD/Lt mice congenic for the severe combined immunodeficiency (scid) mutation have provided great insight to the contributions of various T-cell populations in the pathogenesis of autoimmune insulin-dependent diabetes mellitus (IDDM). Moreover, NOD-scid mice support higher levels of human lymphohematopoietic cell growth than the C.B-17-scid strain in which the mutation originated. However, the ability to perform long-term lymphohematopoietic repopulation studies in the NOD-scid stock has been limited by the fact that most of these mice develop lethal thymic lymphomas beginning at 20 weeks of age. These thymic lymphomas are characterized by activation and subsequent genomic reintegrations of Emv30, an endogenous murine ecotropic retrovirus unique to the NOD genome. To test the role of this endogenous retrovirus in thymomagenesis, we produced a stock of Emv30null NOD-scid mice by congenic replacement of the proximal end of chromosome 11 with genetic material derived from the closely related NOR/Lt strain. Thymic lymphomas still initiate in Emv30null NOD-scid females, but their rate of progression is significantly retarded since the frequency of tumors weighing between 170 and 910 mg at 25 weeks of age was reduced to 20.8% vs. 76.2% in Emv30% segregants. The thymic lymphomas that did develop in Emv30null NOD-scid mice were not characterized by a compensatory increase in mink cell focus–forming proviral integrations, which initiate thymomagenesis in other susceptible mouse strains. Significantly, the ability of standard NOD T-cells to transfer IDDM to the Emv30null NOD-scid stock was not impaired. Similarly, the elimination of Emv30 did notabrogate the enhanced ability of NOD-scid mice to support the growth of human peripheral blood leukocytes. These findings coupled with the slowed progression of thymic lymphomas indicate that Emv30null NOD-scid mice are an improved,but not yet optimal, recipient for long-term
Skip Nav Destination
Article navigation
Original Articles|
December 01 1995
Emv30null NOD-scid Mice: An Improved Host for Adoptive Transfer of Autoimmune Diabetes and Growth of Human Lymphohematopoietic Cells
David V Serreze;
David V Serreze
The Jackson Laboratory
Bar Harbor, Maine
Search for other works by this author on:
Edward H Leiter;
Edward H Leiter
The Jackson Laboratory
Bar Harbor, Maine
Search for other works by this author on:
Matthew S Hanson;
Matthew S Hanson
The Jackson Laboratory
Bar Harbor, Maine
Search for other works by this author on:
Sherri W Christianson;
Sherri W Christianson
The Jackson Laboratory
Bar Harbor, Maine
Search for other works by this author on:
Leonard D Shultz;
Leonard D Shultz
The Jackson Laboratory
Bar Harbor, Maine
Search for other works by this author on:
RuthAnn M Hesselton;
RuthAnn M Hesselton
Departments of Pediatrics, University of Massachusetts Medical School
Worcester, Massachusetts
Search for other works by this author on:
Dale L Greiner
Dale L Greiner
Departments of Medicine, University of Massachusetts Medical School
Worcester, Massachusetts
Search for other works by this author on:
Address correspondence and reprint requests to Dr. David V. Serreze, The Jackson Laboratory, Bar Harbor, ME 04609.
1
FACS, fluorescence-activated cell sorter; FITC, fluoroisothiocyanate; IDDM, insulin-dependent diabetes mellitus; MCF, mink cell focus–forming; MHC, major histocompatability complex; NK, natural killer; PBL, peripheral blood leukocyte; TCR, T-cell receptor.
Diabetes 1995;44(12):1392–1398
Article history
Received:
May 22 1995
Revision Received:
August 10 1995
Accepted:
August 10 1995
PubMed:
7589844
Citation
David V Serreze, Edward H Leiter, Matthew S Hanson, Sherri W Christianson, Leonard D Shultz, RuthAnn M Hesselton, Dale L Greiner; Emv30null NOD-scid Mice: An Improved Host for Adoptive Transfer of Autoimmune Diabetes and Growth of Human Lymphohematopoietic Cells. Diabetes 1 December 1995; 44 (12): 1392–1398. https://doi.org/10.2337/diab.44.12.1392
Download citation file:
139
Views